Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. - Wikidata - awgldk - TriplyDB

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

http://www.wikidata.org/entity/Q33399520

about

HUS and TTP in Children A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.Exploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the rat Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?Atypical HUS: time to take stock of current guidelines and outcome measures?Postoperative hemolytic uremic syndrome with renal cortical necrosis following laparoscopic hemicolectomy.Fatal hemolytic uremic syndrome associated with day care surgery and anaesthesia: a case report.Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab."Almost bleeding to death": the conundrum of acquired amegakaryocytic thrombocytopenia.A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.End-stage renal disease from hemolytic uremic syndrome in the United States, 1995-2010 Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia.Long-term outcomes of thrombotic microangiopathy treated with plasma exchange: A systematic review.Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report.Early eculizumab use in atypical haemolytic uraemic syndrome in a Jehovah's Witness refusing blood products Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injury The effects of Eculizumab on the pathology of malignant atrophic papulosis.Lessons and insights from ABO-incompatible lung transplantation.The role of von Willebrand factor in thrombotic microangiopathy.

P2860

Q27026538-E43188E0-7639-4FEE-9E49-FC567D9FA4C4 Q28661698-3A418D50-9015-427F-9A87-BFE705061E1D Q31010561-E5EB5472-B9B8-4897-95B2-5BC5A72EE648 Q33402623-6DC2A12A-18FC-4DE7-A697-26EE42FF4135 Q33402876-F17A1FB3-F761-4F1A-AEB5-CDEBB6B318EF Q33404359-C6108C54-E53D-4615-863E-85243DBDC8F8 Q33405728-A70FBE88-9B55-4CF9-A7D9-24D62A0E753F Q33406887-12F32AB4-4668-4D53-87FB-A273C1EEA676 Q33408687-DAAC8C61-B10D-4055-8CBF-CF46C74DA3D6 Q33409030-758441D4-AAC0-4880-A101-27A002739827 Q33411321-EA6D0BDC-2463-46E3-88A9-66CEA429CE7C Q33411744-C1458640-EB95-47E8-A5DC-0B5F135213D9 Q33411810-FDACD492-B7A5-4331-97CD-70FE8F945ACD Q33414082-1E0A32A9-994E-40FD-A061-CAA80279BB4F Q33418553-FD48A2FC-07ED-45E5-891B-B6E729944E3F Q33420509-E51B3B53-FE9A-430F-9251-749A071B5CAB Q33423051-1D308BBF-EEE0-489A-BF48-2D96A37ECBA7 Q33424960-58122714-613F-4D8C-B147-B16E5E8221A5 Q33430254-D2FA2AD6-3DA5-4D96-BED1-D42522415314 Q33441871-83A0FBF2-4AC8-4F66-86DE-0FA1B8E4261B Q33442901-B67975F1-8A1C-45BE-9719-BC8018CB0403 Q35668667-A3098BA7-6593-4670-9CC5-85DB992DC007 Q35891577-2AAE1FF9-1E53-495B-9F5B-950B8C36EE23 Q38394033-6C4EF0AF-00B2-41C4-BFFB-5A2207F53578 Q39456445-98A682F4-429F-4CC6-9DAE-2F424B047224 Q48338971-0611B908-41BA-48B8-8AF0-07CD859C03C1

P2860

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

http://www.wikidata.org/entity/Q33399520

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

@ast

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

@en

type

label

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

@ast

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

@en

prefLabel

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

@ast

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

@en

P1433

Q33399520-D7A0DBDC-D422-461C-A040-BDBEBDA27E3F

P1476

Q33399520-93A06E75-6B3F-4ECD-A10B-BB1230112E14

P2093

Q33399520-2E018751-E885-4AD9-9E43-7D0807169A8B

P2860

Q33399520-010E5AD9-CE2A-4EDF-A9D7-0B654A34FCCE

Q33399520-06FD3E26-8899-4498-9D7A-753795A09CF2

Q33399520-1050C799-0830-4760-8A65-7D4D4D2F9E65

Q33399520-162E882E-D8DA-4A8D-A10E-70EDBDB37C7F

Q33399520-23B3B9BE-96BD-44ED-AE50-0ED04E7E1ED2

Q33399520-317A27B5-B0D9-4257-99CB-7A5A4402219E

Q33399520-3AE63223-3FCD-4A46-9FEC-15571BC2854F

Q33399520-3B2CD76B-DBCD-45A2-A521-A4B58B6E2CC5

Q33399520-42A48409-FC06-4EBA-81CF-5AD2149F9362

Q33399520-4BD41AC4-BCDC-4D7C-87C5-E162BCD20F22

P304

Q33399520-4711FA3A-9180-42E2-9C55-B0416C78C43C

P31

Q33399520-F90773D1-C364-4C3F-BF03-94AE7D8991B7

P356

Q33399520-550F7041-EC99-4E03-93A7-01DDA37D75EA

P433

Q33399520-673C341B-2F91-4262-A609-02B60C7F7283

P478

Q33399520-7C8D91A3-486A-46A2-B253-0D55A1A7CF85

P577

Q33399520-E53542C2-C503-4F25-A226-301E929C7182

P698

Q33399520-32834A87-7307-48D6-8008-BF492BE9BC06

P356

J.1525-139X.2011.01035.X

P1433

Seminars in Dialysis

P1476

Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

@en

P2093

William F Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura.

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.

Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions.

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

P304

214-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1525-139X.2011.01035.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22309967

http://www.w3.org/2001/XMLSchema#string